Outcome analysis with regard to tumor subtype showed a worse DFS (Fig. 3) and OS (Fig. 4) in patients with salivary duct carcinoma and PD-L1 expressing TIIC (p = 0.022 and p = 0.003, respectively). This evidence concerns the gene CD274 and salivary duct carcinoma.